Efficacy News and Research

RSS
PURE Bioscience introduces new Hard Surface disinfectant

PURE Bioscience introduces new Hard Surface disinfectant

Study finds increase in implementation of evidence-based therapies for myocardial infarction

Study finds increase in implementation of evidence-based therapies for myocardial infarction

Positive results from Shire's Vyvanse clinical trial in schizophrenia

Positive results from Shire's Vyvanse clinical trial in schizophrenia

Molecular Partners completes MP0112 phase I/IIa trials in wet AMD, DME

Molecular Partners completes MP0112 phase I/IIa trials in wet AMD, DME

Seattle BioMed study to identify biomarkers for malaria vaccine design

Seattle BioMed study to identify biomarkers for malaria vaccine design

The Lancet publishes phase 3 clinical study data on VIVITROL for treatment of opioid dependence

The Lancet publishes phase 3 clinical study data on VIVITROL for treatment of opioid dependence

New study reveals a novel gene linked with major depression

New study reveals a novel gene linked with major depression

Neovasc 2010 consolidated net loss decreases to $2,630,885

Neovasc 2010 consolidated net loss decreases to $2,630,885

CESAR, Saladax begin patient enrollment in paclitaxel CEPAC-TDM trial for NSCLC

CESAR, Saladax begin patient enrollment in paclitaxel CEPAC-TDM trial for NSCLC

Children, adolescents with liver disease may not benefit from vitamin E or metformin

Children, adolescents with liver disease may not benefit from vitamin E or metformin

BioInvent, ThromboGenics initiate TB-402 Phase IIb trial for VTE prophylaxis

BioInvent, ThromboGenics initiate TB-402 Phase IIb trial for VTE prophylaxis

IQ Therapeutics completes dosing in IQNLF Phase I trial for anthrax

IQ Therapeutics completes dosing in IQNLF Phase I trial for anthrax

Tarix begins patient enrollment for TXA127 Phase 1 study in DCBT

Tarix begins patient enrollment for TXA127 Phase 1 study in DCBT

Motor regulatory protein can block human ovarian tumor growth

Motor regulatory protein can block human ovarian tumor growth

FDA supports new Hepatitis C drug from Vertex Pharmaceuticals

FDA supports new Hepatitis C drug from Vertex Pharmaceuticals

Diabetes and prediabetes are on the rise: New medication in research trials

Diabetes and prediabetes are on the rise: New medication in research trials

Tai chi for heart failure patients: It works!

Tai chi for heart failure patients: It works!

BioControl Medical initiates INOVATE-HF study of CardioFit system

BioControl Medical initiates INOVATE-HF study of CardioFit system

PolyMedix defensin-mimetic antibiotic compounds show antimicrobial efficacy against anthrax

PolyMedix defensin-mimetic antibiotic compounds show antimicrobial efficacy against anthrax

Merck receives Health Canada approval for GARDASIL to treat HPV in women upto age 45

Merck receives Health Canada approval for GARDASIL to treat HPV in women upto age 45

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.